Abcd2 - ATP binding cassette subfamily D member 2 Gene

Also Known as ALDR

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 84356

Summary

Enables protein heterodimerization activity and protein homodimerization activity. Involved in very long-chain fatty acid catabolic process. Located in peroxisomal membrane. Orthologous to human ABCD2 (ATP binding cassette subfamily D member 2). [provided by Alliance of Genome Resources, Apr 2022]

Abcd2 Products (1)

mRNA Protein Name
NM_033352.2 NP_203503.2 ATP-binding cassette sub-family D member 2

Gene Ontology

  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence References Source
enables protein binding IPI
IPI: Inferred from physical interaction
21209459 RGD
enables protein heterodimerization activity IDA
IDA: Inferred from direct assay
28258215 RGD
enables protein homodimerization activity IDA
IDA: Inferred from direct assay
28258215 RGD
Biological Process GO Annotation Evidence References Source
involved in very long-chain fatty acid catabolic process IMP
IMP: Inferred from mutant phenotype
25043761 RGD
involved in very long-chain fatty acid metabolic process IMP
IMP: Inferred from mutant phenotype
21209459 RGD
Cellular Component GO Annotation Evidence References Source
located in peroxisomal membrane IDA
IDA: Inferred from direct assay
14561759 RGD
located in peroxisome IDA
IDA: Inferred from direct assay
25043761 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

ATP-binding cassette sub-family D member 2

  • ATP-binding cassette, sub-family D (ALD), member 2

  • ATP-binding cassette, subfamily D (ALD), member 2

  • adrenoleukodystrophy-related protein

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-160004 PXL770 Activator 99.56% Phase 2
HY-156679 VK-0214 Antagonist 99.87% Phase 1

Pre-clinical Phase

Bioactive Molecules (8)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-183032 ABC transporter modulator-1 Activator 96.30% Unkown
HY-183033 ABC transporter modulator-2 Activator 96.89% Unkown
HY-183034 ABC transporter modulator-3 Activator 97.0% Unkown
HY-183035 ABC transporter modulator-4 Modulator / Unkown
HY-183036 ABC transporter modulator-5 Modulator / Unkown
HY-RS00069 ABCD2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS02086 CCL17 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS16826 Ccl17 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Abcd2 NCBI NCBI:225